Leland Stanford Junior University

Guy Haskin Fernald

Russ B Altman

Nicholas Tatonetti

An algorithm according to an embodiment of the present invention provides for latent signal detection of adverse events. Embodiments infer the presence of adverse drug events from large observational databases housed by the FDA, WHO, and other governmental organizations. The disclosed algorithms do not require the adverse event to be reported explicitly. Instead, the algorithms infer the presence of adverse events through more common secondary effects. In an embodiment, machine learning techniques are used for this purpose.

Growing community of inventors

San Francisco, CA, United States of America

Guy Haskin Fernald